Integrated BioPharma, Inc. (INBP)
OTCMKTS: INBP · Delayed Price · USD
0.215
0.00 (0.00%)
Apr 9, 2024, 11:42 AM EDT - Market open
Integrated BioPharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.32 | 0.33 | 0.21 | 0.4 | 0.48 | 0.23 | 0.13 | 0.4 | 0.07 | 0.45 | Upgrade
|
| Short-Term Investments | 0 | 0.01 | 0.07 | 0.13 | 0.08 | 0 | 0.47 | 0.5 | 0.5 | 0.53 | Upgrade
|
| Cash & Cash Equivalents | 1.32 | 0.33 | 0.21 | 0.4 | 0.48 | 0.23 | 0.6 | 0.9 | 0.57 | 0.98 | Upgrade
|
| Cash Growth | 297.58% | 57.62% | -47.76% | -15.37% | 108.33% | -61.81% | -33.37% | 56.64% | -41.81% | 33.02% | Upgrade
|
| Receivables | 4.51 | 4.89 | 5.78 | 5.51 | 4.44 | 3.8 | 4.02 | 3.14 | 2.64 | 2.18 | Upgrade
|
| Inventory | 10.26 | 11.06 | 11.7 | 10.1 | 8.82 | 7.74 | 7.65 | 7.76 | 5.78 | 5.7 | Upgrade
|
| Other Current Assets | 0.28 | 0.34 | 0.25 | 0.32 | 0.26 | 0.39 | 0.29 | 0.28 | 0.33 | 0.31 | Upgrade
|
| Total Current Assets | 16.37 | 16.63 | 18 | 16.46 | 14.08 | 12.15 | 12.55 | 12.07 | 9.32 | 9.17 | Upgrade
|
| Property, Plant & Equipment | 4.28 | 3.78 | 4.11 | 4.52 | 5.06 | 1.65 | 1.6 | 1.57 | 1.37 | 1.24 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.21 | 0 | 0.3 | Upgrade
|
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0.24 | 0.74 | 0.88 | Upgrade
|
| Other Long-Term Assets | 4.78 | 4.85 | 3.34 | 1.96 | 0.65 | 0.73 | 1.04 | 0 | 0.19 | 0 | Upgrade
|
| Total Long-Term Assets | 9.06 | 8.62 | 7.44 | 6.48 | 5.71 | 2.41 | 2.65 | 2.02 | 2.3 | 2.42 | Upgrade
|
| Total Assets | 25.43 | 25.25 | 25.44 | 22.94 | 19.79 | 14.57 | 15.2 | 14.09 | 11.62 | 11.58 | Upgrade
|
| Accounts Payable | 2.27 | 3.21 | 3.5 | 4.36 | 3.86 | 4.18 | 4.18 | 5.47 | 4.86 | 5.64 | Upgrade
|
| Deferred Revenue | -2.27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Current Debt | 0.93 | 0.64 | 4.13 | 7.36 | 7.35 | 10.94 | 5.79 | 5.14 | 5.18 | 4.71 | Upgrade
|
| Other Current Liabilities | 3.9 | 1.41 | 1.61 | 1.38 | 1.15 | 1.06 | 1.18 | 1.21 | 1.83 | 1.31 | Upgrade
|
| Total Current Liabilities | 4.83 | 5.26 | 9.24 | 13.1 | 12.35 | 16.18 | 11.16 | 11.82 | 11.87 | 11.65 | Upgrade
|
| Long-Term Debt | 1.74 | 1.41 | 1.87 | 3.78 | 5.54 | 3.62 | 9.47 | 10.51 | 9.06 | 9.37 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0.08 | 0.01 | 0.72 | Upgrade
|
| Total Long-Term Liabilities | 1.74 | 1.41 | 1.87 | 3.78 | 5.54 | 3.62 | 9.97 | 10.59 | 9.07 | 10.09 | Upgrade
|
| Total Liabilities | 6.57 | 6.68 | 11.11 | 16.88 | 17.9 | 19.8 | 21.13 | 22.41 | 20.94 | 21.74 | Upgrade
|
| Total Debt | 2.67 | 2.06 | 6 | 11.14 | 12.9 | 14.56 | 15.26 | 15.66 | 14.24 | 14.08 | Upgrade
|
| Debt Growth | 30.02% | -65.75% | -46.12% | -13.65% | -11.44% | -4.59% | -2.52% | 9.92% | 1.18% | -7.39% | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Retained Earnings | -32.34 | -32.31 | -36.14 | -44.16 | -48.26 | -49.95 | -50.63 | -52.98 | -53.94 | -54.67 | Upgrade
|
| Comprehensive Income | 0 | 0 | 0 | 0 | 0 | -6.79 | -6.71 | -6.44 | -6.41 | -6.31 | Upgrade
|
| Shareholders' Equity | 18.86 | 18.58 | 14.33 | 6.07 | 1.89 | -5.24 | -5.93 | -8.33 | -9.32 | -10.16 | Upgrade
|
| Total Liabilities and Equity | 25.43 | 25.25 | 25.44 | 22.94 | 19.79 | 14.57 | 15.2 | 14.09 | 11.62 | 11.58 | Upgrade
|
| Net Cash / Debt | -1.36 | -1.71 | -5.72 | -10.6 | -12.34 | -14.33 | -14.66 | -14.76 | -13.67 | -13.09 | Upgrade
|
| Net Cash Per Share | -0.05 | -0.05 | -0.18 | -0.34 | -0.42 | -0.47 | -0.49 | -0.70 | -0.47 | -0.62 | Upgrade
|
| Working Capital | 11.54 | 11.36 | 8.76 | 3.36 | 1.73 | -4.03 | 1.4 | 0.25 | -2.54 | -2.49 | Upgrade
|
| Book Value Per Share | 0.63 | 0.62 | 0.48 | 0.21 | 0.07 | -0.17 | -0.28 | -0.39 | -0.44 | -0.48 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.